Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$RGBP and $RGBPP
Oncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer Vaccine
Oncology Pharma ( $ONPH ) $5.24
52 Week high $50
https://finance.yahoo.com/news/oncology-pharma-inc-regen-biopharma-123000344.html
$BCLI BrainStorm Cell Therapeutics to Present at the 12th Annual California ALS Research Summit
https://finance.yahoo.com/news/brainstorm-cell-therapeutics-present-12th-120000759.html
$AIAD Weekly chart
52 weeks high @.18
Authorized Shares 2,000,000,000
Outstanding Shares 1,055,556,518
Restricted 128,410,616
Unrestricted 927,145,902
https://www.otcmarkets.com/stock/AIAD/security
$AIAD Total Revenue
https://www.otcmarkets.com/stock/AIAD/financials
4 OTC Stocks Set to Explode: AIAD LQMT SIRC UNQL
https://insiderfinancial.com/4-otc-stocks-set-to-explode-aiad-lqmt-sirc-unql/182915/
$AIAD does seem part of the Trump $DWAC / #CFVI ecosystem and may be poised to benefit from it.
$AIAD Weekly chart
52 weeks high @.18
Authorized Shares 2,000,000,000
Outstanding Shares 1,055,556,518
Restricted 128,410,616
Unrestricted 927,145,902
https://www.otcmarkets.com/stock/AIAD/security
$AIAD Total Revenue
https://www.otcmarkets.com/stock/AIAD/financials
4 OTC Stocks Set to Explode: AIAD LQMT SIRC UNQL
https://insiderfinancial.com/4-otc-stocks-set-to-explode-aiad-lqmt-sirc-unql/182915/
$AIAD does seem part of the Trump $DWAC / #CFVI ecosystem and may be poised to benefit from it.
ALS community petitions BrainStorm and the FDA to urgently determine a path forward for NurOwn
https://iamals.org/action/brainstorm-fda-petition/
$AIAD
Trump Stocks Alert: What Is Going on With DWAC, PHUN, CFVI, AIAD Stocks Today?
https://investorplace.com/2022/01/trump-stocks-alert-what-is-going-on-with-dwac-phun-cfvi-aiad-stocks-today/
$AIAD
Trump Stocks Alert: What Is Going on With DWAC, PHUN, CFVI, AIAD Stocks Today?
https://investorplace.com/2022/01/trump-stocks-alert-what-is-going-on-with-dwac-phun-cfvi-aiad-stocks-today/
$NES Low Float
2.68% Held by All Insider
91.51% Held by Institutions
Cost to Borrow Average 213.41%
https://investorshub.advfn.com/uimage/uploads/2022/1/13/cdflbNes_cost_to_borrow.png
$NES Low Float
2.68% Held by All Insider
91.51% Held by Institutions
Cost to Borrow Average 213.41%
https://investorshub.advfn.com/uimage/uploads/2022/1/13/cdflbNes_cost_to_borrow.png
$BCLI Nomination of Robert Califf to be Commissioner of Food and Drugs Administration
https://www.help.senate.gov/hearings/nominations1522
$EVIO LORI GLAUSER CEO
https://www.otcmarkets.com/stock/EVIO/profile
MBA with 25 years experience including IBM, Ernst & Young, and Financial Times
https://eviolabs.com/team/lori-glauser/
$EVIO LORI GLAUSER CEO
https://www.otcmarkets.com/stock/EVIO/profile
MBA with 25 years experience including IBM, Ernst & Young, and Financial Times
https://eviolabs.com/team/lori-glauser/
$DWAC $60
$DWACW $16
DWACW Exercise price $11.50
DWACW should be trading much higher
$DWAC $60
$DWACW $16
DWACW Exercise price $11.50
DWACW should be trading much higher
$EVIO 0005 / 0006
52 weeks high .017
Total Revenue
2019: 3,789M
2018: 3,365M
2017: 3,021M
Price near the bottom
$EVIO 0005 / 0006
— friendva1 (@friendva1) January 5, 2022
52 weeks high .017
Total Revenue
2019: 3,789M
2018: 3,365M
2017: 3,021M
Price near the bottom https://t.co/7COiMMWfFf pic.twitter.com/A5MJ94V06P
$EVIO 0005 / 0006
52 weeks high .017
Total Revenue
2019: 3,789M
2018: 3,365M
2017: 3,021M
Price near the bottom
$EVIO 0005 / 0006
— friendva1 (@friendva1) January 5, 2022
52 weeks high .017
Total Revenue
2019: 3,789M
2018: 3,365M
2017: 3,021M
Price near the bottom https://t.co/7COiMMWfFf pic.twitter.com/A5MJ94V06P
$BCLI recent development
1. FDA Authorizes Further NurOwn Dosing Under EAP.
2. FDA approved BrainStorm to manufacture NurOwn for the EAP at the Catalent facility.
3. Positive peer reviewed publication of NurOwn's Phase 3 Study for ALS.
4. Accelerating Access to Critical Therapies for ALS Act approved and signed.
5. Zacks Small Cap Research increased $BCLI valuation to $14.
$BCLI recent development
1. FDA Authorizes Further NurOwn Dosing Under EAP.
2. FDA approved BrainStorm to manufacture NurOwn for the EAP at the Catalent facility.
3. Positive peer reviewed publication of NurOwn's Phase 3 Study for ALS.
4. Accelerating Access to Critical Therapies for ALS Act approved and signed.
5. Zacks Small Cap Research increased $BCLI valuation to $14.
FDA Approval for Life-Saving Nurown for ALS Patients - Sign the Petition!
273,925 have signed
https://www.change.org/p/fda-approval-for-life-saving-nurown-for-als-patients?recruiter=1243891940&utm_source=share_petition&utm_medium=twitter&utm_campaign=psf_combo_share_message&utm_term=psf_combo_share_initial&recruited_by_id=62293cf0-692c-11ec-a449-0b93cf51bd07&share_bandit_exp=message-14639127-en-US&share_bandit_var=v1
$AHFD 0005 / 0006
one of the cheapest NFT / Crypto play
SS update 12/27/2021
Unrestricted 4,612,881,403
$AHFD 0005 / 0006
one of the cheapest NFT / Crypto play
SS update 12/27/2021
Unrestricted 4,612,881,403
$BCLI FDA Authorizes Further NurOwn® Dosing Under Expanded Access Program
https://finance.yahoo.com/news/fda-authorizes-further-nurown-dosing-120000815.html
$BCLI FDA Authorizes Further NurOwn® Dosing Under Expanded Access Program
https://finance.yahoo.com/news/fda-authorizes-further-nurown-dosing-120000815.html
Accelerating Access to Critical Therapies for ALS Act passed the senate!
$BCLI Senate List 61 sponsors for S.1813 - Accelerating Access to Critical Therapies for ALS Act
$BCLI from Earnings Call Transcript
Stacy Lindborg: And I'm just shared on this call, we've made great progress with these goals and immediately after the publication is in print, we will be prepared to speak to our plans for BLA filing.
$APT MASK PLAY
Float 11.9 M
Short Interest 14.45%
$APT MASK PLAY
Float 11.9 M
Short Interest 14.45%
$BCLI Senate List 59 sponsors for S.1813 - Accelerating Access to Critical Therapies for ALS Act
$BCLI Upcoming Catalysts IMO
- Submit BLA
- Senate Approval of S.1813 - Accelerating Access to Critical Therapies for ALS Act.
- Alzheimer potential partners, which include mid-sized and leading pharmaceutical companies.
- More upgrades
- Progress on other fronts
- Maybe Buyout offer
$BCLI Upcoming Catalysts IMO
- Submit BLA
- Senate Approval of S.1813 - Accelerating Access to Critical Therapies for ALS Act.
- Alzheimer potential partners, which include mid-sized and leading pharmaceutical companies.
- More upgrades
- Progress on other fronts
- Maybe Buyout offer
$BCLI $14 Price Target today
Current Price $3.97
https://s27.q4cdn.com/906368049/files/News/2021/Zacks_SCR_Research_12132021_BCLI_Bautz.pdf